At the same time that Johnson & Johnson continues to refute claims that it’s talcum based baby powder increases the risk of cancer, it continues to lose in court with almost every civil action that they face based on the simple fact, that there are scientific studies proving that they should have and most probably did know about the increased risk of cancer from their products since 1964, but failed to warn the public.
On Monday, a Los Angeles jury awarded a whopping $417 million in a civil action against Johnson & Johnson for claims that their talcum powder based products, caused a 63-year-old woman’s ovarian cancer.
In the post-verdict interview, the lawyer for stated that the case was won base and the fact that Johnson & Johnson should have known that talcum powder was carcinogenic since there have been clinical studies showing it to be a carcinogen since 1964, but Johnson & Johnson argued partly, that because the CDC does not list talc as being carcinogenic, then they should be let off the hook.
That didn’t work for Johnson & Johnson, and it hasn’t worked in 4 out of the 5 civil action lawsuits that they have faced, with over $750 million in awards to those who have won their civil suits against them, in recent years.
But this bad day in Johnson & Johnson’s history, is not going to end there. As it is reported that there are over 1000 additional women with filed civil claims in the United States, for Johnson & Johnson’s baby powder, causing ovarian cancer.
This appears to be just another case of profits trumping ethics for one more pharmaceutical and consumer product, corporation. But for me, I’m very happy to see at least one of them finally being held financially accountable, in a manner that will offset the profits that they made from these products. However, I still long for a day when the executives of these companies that were directly responsible, are criminally prosecuted as they are now beginning to do in a few other countries.
It is only when people start going to jail for their criminal activities, that the executives of these pharmaceutical and consumer product companies, will start making ethical decisions or risk giving up their personal freedom through incarceration for their crimes against the public.